Metformin in the prevention of type 2 diabetes after gestational diabetes in postnatal women (OMAhA): a UK multicentre randomised, placebo-controlled, double-blind feasibility trial with nested qualitative study

OBJECTIVE: To determine the feasibility of a definitive trial of metformin to prevent type 2 diabetes in the postnatal period in women with gestational diabetes. DESIGN: A multicentre, placebo-controlled, double-blind randomised feasibility trial with qualitative evaluation. SETTING: Three inner-cit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolou, Angeliki, Drymoussi, Zoe, Lanz, Doris, Amaefule, Chiamaka Esther, Gonzalez Carreras, Francisco Jose, Pardo Llorente, Maria del Carmen, Dodds, Julie, Pizzo, Elena, Thomas, Amy, Heighway, James, Harden, Angela, Sanghi, Anita, Hitman, Graham, Zamora, Javier, Pérez, Teresa, Huda, Mohammed S B, Thangaratinam, Shakila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685917/
https://www.ncbi.nlm.nih.gov/pubmed/38016790
http://dx.doi.org/10.1136/bmjopen-2023-073813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685917/
https://www.ncbi.nlm.nih.gov/pubmed/38016790
http://dx.doi.org/10.1136/bmjopen-2023-073813

Ejemplares similares